These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 31534972)

  • 1. The Efficacy and Mechanism of Chinese Herbal Medicine on Diabetic Kidney Disease.
    Lu Z; Zhong Y; Liu W; Xiang L; Deng Y
    J Diabetes Res; 2019; 2019():2697672. PubMed ID: 31534972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of traditional Chinese herbal medicine in patients with diabetic kidney disease: study protocol for a randomized controlled trial.
    Wang M; Wang Z; Zhou J; Sun W; Wang Y; Han M; Yang H; Liu WJ; Wang Y
    Trials; 2018 Jul; 19(1):389. PubMed ID: 30016983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese herbal medicine and its active compounds in attenuating renal injury
    Liu P; Zhu W; Wang Y; Ma G; Zhao H; Li P
    Front Endocrinol (Lausanne); 2023; 14():1142805. PubMed ID: 36942026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese herbal medicine for diabetic kidney disease: a systematic review and meta-analysis of randomised placebo-controlled trials.
    Zhang L; Yang L; Shergis J; Zhang L; Zhang AL; Guo X; Qin X; Johnson D; Liu X; Lu C; Xue CC; Mao W
    BMJ Open; 2019 May; 9(4):e025653. PubMed ID: 31048437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chinese medicine for diabetic kidney disease in China.
    Wen Y; Yan M; Zhang B; Li P
    Nephrology (Carlton); 2017 Dec; 22 Suppl 4():50-55. PubMed ID: 29155500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese herbal medicine Tangshen Formula treatment of patients with type 2 diabetic kidney disease with macroalbuminuria: study protocol for a randomized controlled trial.
    Yan M; Wen Y; Yang L; Wu X; Lu X; Zhang B; Huang W; Li P
    Trials; 2016 May; 17(1):259. PubMed ID: 27216240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese Herbal Medicine in Ameliorating Diabetic Kidney Disease via Activating Autophagy.
    Wang Y; Zhao H; Wang Q; Zhou X; Lu X; Liu T; Zhan Y; Li P
    J Diabetes Res; 2019; 2019():9030893. PubMed ID: 31828168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.
    Zhan H; Jin J; Liang S; Zhao L; Gong J; He Q
    Histol Histopathol; 2019 Aug; 34(8):943-952. PubMed ID: 30839094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising therapeutic mechanism for Chinese herbal medicine in ameliorating renal fibrosis in diabetic nephropathy.
    Wang S; Qin S; Cai B; Zhan J; Chen Q
    Front Endocrinol (Lausanne); 2023; 14():932649. PubMed ID: 37522131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanisms underlying Chinese medicines to treat inflammation in diabetic kidney disease.
    Deng L; Shi C; Li R; Zhang Y; Wang X; Cai G; Hong Q; Chen X
    J Ethnopharmacol; 2024 Oct; 333():118424. PubMed ID: 38844252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Chinese Herbal Medicine plus usual care for diabetic kidney disease: study protocol for a randomized, double-blind, placebo-controlled pilot trial.
    Liu M; Di YM; Zhang L; Yang L; Zhang L; Chen J; Wang R; Xie X; Lan F; Xie L; Huang J; Zhang AL; Xue CC; Liu X
    Front Endocrinol (Lausanne); 2024; 15():1334609. PubMed ID: 38390199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Traditional Chinese Medicine research in diabetic kidney disease treatment.
    Shen S; Zhong H; Zhou X; Li G; Zhang C; Zhu Y; Yang Y
    Pharm Biol; 2024 Dec; 62(1):222-232. PubMed ID: 38357845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of progression of diabetic kidney disease mediated by podocyte mitochondrial injury.
    Su J; Ye D; Gao C; Huang Q; Gui D
    Mol Biol Rep; 2020 Oct; 47(10):8023-8035. PubMed ID: 32918716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis.
    Sun J; Wang Y; Cui W; Lou Y; Sun G; Zhang D; Miao L
    J Diabetes Res; 2017; 2017():7242384. PubMed ID: 28695133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Pathobiology of Diabetic Kidney Disease.
    Thomas MC
    Adv Chronic Kidney Dis; 2021 Jul; 28(4):282-289. PubMed ID: 34922684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease.
    Falkevall A; Mehlem A; Palombo I; Heller Sahlgren B; Ebarasi L; He L; Ytterberg AJ; Olauson H; Axelsson J; Sundelin B; Patrakka J; Scotney P; Nash A; Eriksson U
    Cell Metab; 2017 Mar; 25(3):713-726. PubMed ID: 28190774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
    Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
    J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E1 for preventing the progression of diabetic kidney disease.
    Wang H; Deng JL; Yue J; Li J; Hou YB
    Cochrane Database Syst Rev; 2010 May; (5):CD006872. PubMed ID: 20464745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular endothelial cell injury and cross talk in diabetic kidney disease.
    Fu J; Lee K; Chuang PY; Liu Z; He JC
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F287-97. PubMed ID: 25411387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research advance in the mechanism for oxidative stress-induced podocyte injury in diabetic kidney disease.
    Ao L; Xie Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1403-1408. PubMed ID: 35232911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.